Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism

von Holland, William L., Summers, Scott A.
Veröffentlicht 2008

PAQRs: A Counteracting Force to Ceramides?

von Holland, William L., Scherer, Philipp E.
Veröffentlicht 2009

Ronning After the Adiponectin Receptors

von Holland, William L., Scherer, Philipp E.
Veröffentlicht 2013

Adiponectin and its Hydrolase-Activated Receptors

von Sharma, Ankit X., Holland, William L.
Veröffentlicht in J Nat Sci (2017)

Strong Heart, Low Ceramides

von Holland, William L., Summers, Scott A.
Veröffentlicht in Diabetes (2018)

Regulation of Glucose and Lipid Homeostasis by Adiponectin: Effects on Hepatocytes, Pancreatic β Cells and Adipocytes

von Tao, Caroline, Sifuentes, Angelica, Holland, William L.
Veröffentlicht in Best Pract Res Clin Endocrinol Metab (2013)

Does This Schlank Make Me Look Fat?

von Chaurasia, Bhagirath, Holland, William L., Summers, Scott A.
Veröffentlicht in Trends Endocrinol Metab (2018)

The ceramide ratio: a predictor of cardiometabolic risk(1)

von Tippetts, Trevor S., Holland, William L., Summers, Scott A.
Veröffentlicht in J Lipid Res (2018)

Metabolic Messengers: ceramides

von Summers, Scott A., Chaurasia, Bhagirath, Holland, William L.
Veröffentlicht in Nat Metab (2019)

Dichotomous roles of leptin and adiponectin as enforcers against lipotoxicity during feast and famine

von Unger, Roger H., Scherer, Philipp E., Holland, William L.
Veröffentlicht 2013

Glucagon antagonism in islet cell proliferation

von Dean, E. Danielle, Unger, Roger H., Holland, William L.
Veröffentlicht in Proc Natl Acad Sci U S A (2017)

Clinical Trials, Triumphs, and Tribulations of Glucagon Receptor Antagonists

von Pearson, Mackenzie J., Unger, Roger H., Holland, William L.
Veröffentlicht in Diabetes Care (2016)

Listen to your heart when ceramide's calling for higher glucose

von Wilkerson, Joseph L., Summers, Scott A., Holland, William L.
Veröffentlicht in EBioMedicine (2019)

Low-Density Lipoprotein Receptor-Related Protein-1 Protects Against Hepatic Insulin Resistance and Hepatic Steatosis

von Ding, Yinyuan, Xian, Xunde, Holland, William L., Tsai, Shirling, Herz, Joachim
Veröffentlicht in EBioMedicine (2016)

PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice

von Lakhia, Ronak, Yheskel, Matanel, Flaten, Andrea, Quittner-Strom, Ezekiel B., Holland, William L., Patel, Vishal
Veröffentlicht in Am J Physiol Renal Physiol (2018)

PPARγ-K107 SUMOylation regulates insulin sensitivity but not adiposity in mice

von Katafuchi, Takeshi, Holland, William L., Kollipara, Rahul K., Kittler, Ralf, Mangelsdorf, David J., Kliewer, Steven A.
Veröffentlicht in Proc Natl Acad Sci U S A (2018)

Differential transendothelial transport of adiponectin complexes

von Rutkowski, Joseph M, Halberg, Nils, Wang, Qiong A, Holland, William L, Xia, Jonathan Y, Scherer, Philipp E
Veröffentlicht 2014

FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection

von Karanth, Santhosh, Chaurasia, Bhagirath, Bowman, Faith M., Tippetts, Trevor S., Holland, William L., Summers, Scott A., Schlegel, Amnon
Veröffentlicht in Physiol Rep (2019)

Depletion of adipocyte sphingosine kinase 1 leads to cell hypertrophy, impaired lipolysis, and nonalcoholic fatty liver disease

von Anderson, Andrea K., Lambert, Johana M., Montefusco, David J., Tran, Bao Ngan, Roddy, Patrick, Holland, William L., Cowart, L. Ashley
Veröffentlicht in J Lipid Res (2020)

Synthesis and Characterization of an A6-A11 Methylene Thioacetal Human Insulin Analog with Enhanced Stability

von Zheng, Nan, Karra, Prasoona, VandenBerg, Michael A., Kim, Jin Hwan, Webber, Matthew J., Holland, William L., Chou, Danny Hung-Chieh
Veröffentlicht in J Med Chem (2019)